Medindia

X

Nu Skin Announces New Scientific Advisor

Monday, January 11, 2010 General News J E 4
Advertisement
Stuart Kim, Ph.D., Provides Expertise on Gene-based Anti-aging Science

PROVO, Utah, Jan. 11 /PRNewswire-FirstCall/ -- Nu Skin Enterprises, Inc. (NYSE: NUS), a premier anti-aging company, announced Stuart Kim, Ph.D., professor at Stanford University in the departments of Developmental Biology and Genetics, as a new member of the Nu Skin Anti-Aging Scientific Advisory Board. Dr. Kim will provide insights on the molecular analysis of aging science.

"We are honored to welcome Dr. Kim to the Nu Skin Anti-Aging Scientific Advisory Board and believe that our collaboration with him will increase our scientific efforts to target the sources of aging," said Joseph Chang, Ph.D., Nu Skin chief scientific officer and executive vice president of product development. "Dr. Kim has spent much of his career studying the genetic basis of aging and has garnered significant attention in the scientific community related to his identification of an important gene that could play a critical role in aging. This important work will add to the further understanding of the molecular mechanism by which certain proteins regulate aging."

Kim received bachelors' degrees in chemistry and philosophy from Dartmouth College in 1979. Dr. Kim then moved to biology at Caltech and received a doctorate in 1984. He spent five years as a post-doctoral fellow at MIT and is currently a professor in the departments of Developmental Biology and Genetics at Stanford University, as well as a faculty affiliate to the Stanford Center on Longevity.

Kim's recent research interests have focused on functional genomics and systems biology. He has produced DNA microarrays for C. elegans and used them to profile gene expression during development and aging. He has also assembled large sets of data from microarray experiments, and used them to find sets of co-regulated genes acting as genetic modules. His developmental drift theory of aging has been published in the scientific journal Cell. Before working on functional genomics, Kim worked on cell polarity in epithelial cells and Ras signaling in C. elegans.

Dr. Kim has been a Markey Scholar, a Searle Scholar and an Ellison Scholar for his research on the genetics of aging. He is an editor of PLOS Genetics, on the National Science Advisory Council for the American Federation for Aging Research and the Scientific Advisory Board for the Buck Institute for Age Research.

Nu Skin Anti- Aging Scientific Advisory Board

Several highly distinguished scientific advisors representing top research and learning institutions around the world combine to form Nu Skin's Anti-Aging Scientific Advisory Board. Nu Skin has brought together leaders in aging, genetics, developmental biology, dermatology and nutrition and the company benefits from their knowledge and experience as it seeks to demonstrate the Nu Skin difference by remaining at the forefront of scientific knowledge and product development. Other scientific advisors include Richard Weindruch, Ph.D., Tomas Prolla, Ph.D., and Zoe Draelos, M.D.

The Company

Nu Skin Enterprises, Inc. demonstrates innovation through its comprehensive anti-aging product portfolio, independent business opportunity and corporate social responsibility initiatives. Nu Skin's scientific leadership in both skin care and nutrition has established Nu Skin as a premier anti-aging company, evidenced in its unique ageLOC™ science that addresses aging at its source. The company's anti-aging products feature the new ageLOC daily skin care system and Future Serum, as well as the Galvanic Spa® System II, Tru Face® Essence Ultra, LifePak® Nano and the g3 nutrition beverage. A global direct selling company, Nu Skin operates in 48 markets worldwide and has more than 750,000 independent sales representatives. Nu Skin is traded on the New York Stock Exchange under the symbol "NUS." More information is available at http://www.nuskin.com.

Please note: This press release contains forward-looking statements that represent the company's current expectations and beliefs which involve risks and uncertainties that could cause actual results and outcomes to differ materially from any forward-looking statements or views expressed herein. The forward-looking statements contained herein are qualified by a detailed discussion of associated risks set forth in the documents filed by the company with the Securities and Exchange Commission, including the company's most recent Form 10-K and Forms 10-Q. 

SOURCE Nu Skin Enterprises, Inc.

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
ViroPharma Expands Global Licensing, Commercializa...
S
MAP Pharmaceuticals Announces FDA will not Require...